मैट्रिक्स
 
 
अजंता फार्मा > कंपनी इतिहास > Pharmaceuticals > कंपनी इतिहास का अजंता फार्मा - बीएसई: 532331, NSE: AJANTPHARM

अजंता फार्मा

बीएसई: 532331  |  NSE: AJANTPHARM  |  ISIN: INE031B01049  |  Pharmaceuticals

कंपनी इतिहास - अजंता फार्मा
2005
 -Max Healthcare to establish India`s first brain lab in New Delhi
 -Max India Ltd  Max telecom ventures Ltd signed a MoU
 
 2008
 -Max India signs agreement with UK firm for health insurance biz
 
 2012
 -Board declares Interim Dividend of 500% i.e. Rs. 10/- for every
 equity share of Rs. 2/- each to the shareholders.
 -Ajanta Pharma Ltd has splits its face value from Rs 10/- to 5/-
 
 
 2013
 - Board recommends Final Dividend 610% amounting to Rs. 12.20 per
 equity share of Rs. 2/- each to the shareholders.
 -Ajanta Pharma has announces bonus in the ratio of 1:2
                                                         
 2014
 -Board recommends Final Dividendof 90%, i.e., Rs. 1.80 for every
 equity share of Rs. 2/- each  to the shareholders
 
 2015
 -Ajanta Pharma Announces the Launch of Montelukast Sodium Oral
 Granules 
 -Launch of Montelukast lR Tablets and Montelukast Chewable Tablets in
 US market
 -Fortune India presents award to Ajanta Pharma
 -Ajanta Pharma gets approvals for 3 ANDA's
 -Ajanta Pharma has splits its face value from Rs. 5 to Rs. 2
 
 2017
 -Ajanta Pharma gets USFDA nod for Duloxetine Hydrochloride.
 -Ajanta Pharma launches Eletriptan Hydrobromide Tablets.
 -Ajanta Pharma launches Clonidine Hydrochloride Extended Release
 Tablets in US.
 -Inaugurated & commissioned 1st phase at a New Facility in Guwahati,
 Assam, India
 - Dahej facility receives successful US FDA approval.
 
 
 
 
स्रोत: रेलीगरे टेचनोवा

न्यूज़ फ़्लैश

  • MARKET CUES : FIIs ने कैश में `1116.79 Cr की बिकवाली की
  • MARKET CUES : DIIs ने कैश में `450.36 Cr की बिकवाली की
  • MARKET CUES : FIIs ने F&O में `58.91 Cr की खरीदारी की
  • MARKET CUES : इंडेक्स फ्यूचर्स में `1197.47 Cr की बिकवाली
  • MARKET CUES : इंडेक्स ऑप्शंस में `1280 Cr की खरीदारी
  • MARKET CUES : स्टॉक फ्यूचर्स में `22.75 Cr की बिकवाली
  • MARKET CUES : स्टॉक ऑप्शंस में `1.60 Cr की बिकवाली
  • CS ON AUROBINDO PHARMA : रेटिंग Neutral से घटाकर Underperform
  • CS ON AUROBINDO PHARMA : लक्ष्य `450/Sh से घटाकर `345/Sh
  • HSBC ON BAJAJ FIN : BUY रेटिंग, लक्ष्य `4,860 से घटाकर `3,750/Sh

अभी देखें

OUR WINNING PICKS

DID YOU INVEST?

INTRADAY PICKS!

(August 06, 2018)

AT (Rs)



GAIN (Rs)

ALL TIME WINNERS

RECO PRICE

PEAK PRICE

OUR PACKAGES

Super Combo

Powerful mix of both trader and investor packs with timely expert advice.

Technical

Designed especially for traders looking to tap the profit opportunities of volatile markets.

Fundamental

For all investors looking to unearth stocks that are poised to move.